News

MS Use Leads to Free Campath for Leukemia Patients

Publish date: August 28, 2012

 

Editor’s note: This story appears courtesy of "The Pink Sheet," a weekly Elsevier publication covering pharmaceutical business and policy issues. To learn more, contact customer care at 800-332-2181 or sign up for a free trial.

Pages

Recommended Reading

FDA Announces Limited Leucovorin Recall
MDedge Hematology and Oncology
FDA Warns of QT Prolongation with Ondansetron Dose
MDedge Hematology and Oncology
Simple Comorbidity Scale Judged Useful in Leukemia
MDedge Hematology and Oncology
Maraviroc Cuts Post-Transplant GVHD Rate in Hematologic Cancers
MDedge Hematology and Oncology
Early BCR-ABL Predicts Survival in Nilotinib-Treated CML
MDedge Hematology and Oncology
2-D Echo Is Inadequate Cardiomyopathy Screen in Childhood Cancer Survivors
MDedge Hematology and Oncology
Blinatumomab Gets Complete Response in Acute Lymphoblastic Leukemia
MDedge Hematology and Oncology
Washington Post Blasts Proliferation of ESAs for Anemia
MDedge Hematology and Oncology
Cancer Patients Differ With Docs on QoL Issues
MDedge Hematology and Oncology
FDA Approves Marqibo for Acute Lymphoblastic Leukemia
MDedge Hematology and Oncology